株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

創傷デブリードマンの世界市場:将来展望

Global Wound Debridement Market - 2019-2026

発行 DataM Intelligence 商品コード 911827
出版日 ページ情報 英文 243 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.78円で換算しております。
Back to Top
創傷デブリードマンの世界市場:将来展望 Global Wound Debridement Market - 2019-2026
出版日: 2019年09月19日 ページ情報: 英文 243 Pages
概要

当レポートでは、世界の創傷デブリードマンの市場について分析し、市場の基本構造および最新情勢、全体的な市場動向の見通し (今後8年間分)、製品別・創傷の種類別・手法別・エンドユーザー別・用途別および地域別の詳細動向、主な市場促進・抑制要因、市場競争構造、主要企業のプロファイル・事業戦略などについて調査しております。

第1章 世界の創傷デブリードマン市場:分析手法・範囲

第2章 世界の創傷デブリードマン市場:市場の定義と概要

第3章 世界の創傷デブリードマン市場:エグゼクティブ・サマリー

第4章 世界の創傷デブリードマン市場:市場のダイナミクス

  • 市場への影響要因
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 影響度の分析

第5章 世界の創傷デブリードマン市場:産業分析

  • ポーターのファイブフォース分析
  • 規制分析
  • サプライチェーン分析
  • 価格動向分析
  • アンメットニーズ

第6章 世界の創傷デブリードマン市場:製品別

  • イントロダクション
    • 市場規模・年間成長率:製品別 (金額ベース、今後9年間分)
    • 市場求心力指標:製品別
  • ゲル
    • イントロダクション
    • 市場規模・年間成長率 (金額ベース、今後9年間分)
  • 超音波装置
  • 手術装置
  • 軟膏・クリーム
  • 医療用ガーゼ
  • 機械的デブリードマン用パッド
  • その他

第7章 世界の創傷デブリードマン市場:創傷の種類別

  • イントロダクション
  • 熱傷
  • 糖尿病性足潰瘍
  • 褥瘡
  • 静脈性下肢潰瘍
  • 手術創・外傷性創傷
  • その他

第8章 世界の創傷デブリードマン市場:手法別

  • イントロダクション
  • 外科的手法
  • 酵素的手法
  • 自己融解的手法
  • 機械的手法
  • その他

第9章 世界の創傷デブリードマン市場:エンドユーザー別

  • イントロダクション
  • 専門クリニック
  • 病院
  • 在宅治療
  • その他

第10章 世界の創傷デブリードマン市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ、メキシコ)
    • イントロダクション
    • 地域固有の市場ダイナミクス
    • 市場規模・年間成長率:製品別 (金額ベース、今後9年間分)
    • 市場規模・年間成長率:創傷の種類別 (金額ベース、今後9年間分)
    • 市場規模・年間成長率:手法別 (金額ベース、今後9年間分)
    • 市場規模・年間成長率:エンドユーザー別 (金額ベース、今後9年間分)
    • 市場規模・年間成長率:国別 (金額ベース、今後9年間分)
  • 欧州 (ドイツ、英国、フランス、イタリア、スペインなど)
  • 南米 (ブラジル、アルゼンチンなど)
  • アジア太平洋地域 (中国、インド、日本、オーストラリアなど)
  • 中東・アフリカ

第11章 世界の創傷デブリードマン市場:競争環境

  • 競争シナリオ
  • 市場ポジショニング/シェア分析
  • 企業合併・買収 (M&A) の分析

第12章 世界の創傷デブリードマン市場:企業プロファイル

  • B. Braun Melsungen AG.
    • 企業概要
    • 製品ポートフォリオ/概略
    • 近年の主な動向
    • 財務分析:概略
  • Acelity L.P., Inc.
  • Smith & Nephew
  • Coloplast A/S
  • ConvaTec Group
  • Paul Hartmann
  • Molnlycke Health Care
  • Lohmann & Rauscher
  • Medline Industries
  • Integra Lifesciences.

第13章 世界の創傷デブリードマン市場:重要考察

第14章 付録

目次

Global Wound Debridement Market Overview

Wound debridement is a process to eliminate the foreign invaders, dead tissues, and toxic substances from human wounds. Wound debridement products aid in lowering the poisonous materials that prevent the wounds from getting healed. Growing geriatric population and the presence of serious wounds are propelling the market.

The global wound debridement market size was worth $ XX billion in 2018 and is expected to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period.

Global Wound Debridement Market Dynamics

The global wound debridement market is driven by the increase in aging population, rise in prevalence of diabetes and associated wounds, increasing number of burn injuries, technological advancements in products, awareness programs for wound care treatment and management, growth in obesity levels and reimbursement policies.

The rising geriatric population is expected to boost the market. Many nations are facing challenges due to the ongoing and the increasing demographic shift in age among their people. As per Department of Economic and Social Affairs Population Division of United Nations, 2017, the world's population who are 60 years old will double and those of 80 years old will triple during the next 30 years. As per WHO, the number of people of age 65 or older is expected to grow to around 1.5 billion in 2050, with most of the increase in the developing countries. Thus, the growing geriatric population, who are more prone to chronic illness, are driving the market.

The technological advancements in the products are expected to boost the market. The advanced therapies are coming into play which is expected to bolster the global wound debridement market. The introduction of a single use negative pressure therapy (NPWT), primarily in-home care settings, is gaining traction. Further, the introduction of ultrasonic devices is expected to drive the wound debridement market. Ultrasonic devices offer benefits like the capacity to differentiate between non-viable and viable tissues. These devices aid in destroying biofilms and bacteria without causing damage to blood vessels. Also, on August 13, 2019, Engineers at Heriot-Watt University developed a tiny electronic sensor that will help medics to heal the wounds by "listening" to them. The microsensor aids in monitoring the tiny, microscale changes in tissue that are taking place below the bandages. Thus, the presence of technological advancements in the products are driving the market.

The growing incidence of chronic ailment such as diabetes is fuelling the global wound debridement market. Diabetic patients are likely to suffer from wounds that do not heal quickly. This may lead to severe wound infections. With the growing number of diabetics across the globe, wound debridement is gaining importance. The International Diabetes Federation reported that by 2040, diabetes incidence is expected to reach 642.0 million. Thus, the growing incidences of diabetes are driving the market.

The presence of ongoing research activities are expected to boost the market. For instance, in December 2018, according to a new research from the McGill University Health Centre (MUHC) and McGill University showed the use of a new application, called Swift Skin and Wound, which measures accurately and charts the progression of skin wounds, could potentially have a significant impact on the clinical management and the patient outcomes. Clinicians and healthcare professionals are currently using the app at the McGill University Health Centre (MUHC) in Montreal. Also, in March 2019, according to a study, published online recently in the journal Scientific Reports by a research team at the Ohio State University, stated that the electroceutical bandages could kill the bacteria around a wound, allowing the wounds to heal faster. Thus, the growing number of research activities are driving the market.

However, the high cost of debridement products and the possible complications after undergoing the wound debridement, are hampering the market.

Complications such as bleeding, removal of healthy tissues by mechanical debridement, and chances of infection through contamination are likely to restrain the market.

Global Wound Debridement Market Segment Analysis

By product, the global wound debridement market is segmented into gels, ointments & creams, surgical devices, medical gauzes, mechanical debridement pads, ultrasonic devices, and others.

Gels segment is expected to boost the market over the forecast period, owing to the advantages such as no inflammation, reduced bleeding, and safe removal of necrotic tissues without causing infection. Also, the presence of research activities using gels are likely to bolster the market. For instance, on October 25, 2018, by incorporating a gene-suppressing drug into an over-the-counter gel, researchers at the Albert Einstein College of Medicine and their colleagues, have reduced the healing time by half and significantly improved the healing outcomes compared to the control treatments. Thus, the added advantages of gels and the presence of research activities are driving the market.

By wound type, the global wound debridement market is segmented into venous leg ulcers, diabetic foot ulcers, pressure ulcers, surgical & traumatic wounds, burns, other wounds.

The burns segment is expected to boost the market, owing to the increasing cases of burns. As per the WHO, an estimated 180 000 deaths occur every year due to burns in low- and middle-income countries. Thus, there is a need to launch different debridement products for healing it. For instance, on April 1, 2019, Kerecis, announced the results of a new case study of Kerecis Omega3 burn product at the Burn Centre of the Queen Elizabeth Hospital Birmingham. It has found that the patients with partial-thickness burn and the donor-site wounds healed quickly, with no infection, after the treatment with the fish-skin graft. Thus, the rising number of burns leading to increasing demand for debridement products are driving the market.

The pressure ulcers segment is expected to boost the market, owing to the rising prevalence of pressure ulcers and the presence of research activities regarding the treatment. According to the Agency for Healthcare Quality and Research, pressure ulcers affect up to 2.5 million patient per year, and related costs range from $9.1 to $11.6 billion per year in the US. They are largely preventable, and 60,000 patients die as a direct result of pressure ulcers each year. For instance, in July 2019, a new randomized control trial evidence confirmed the Repose® as a gold standard for pressure ulcer prevention. In this trial, Professor Dimitri Beeckman and his team have compared the effectiveness of the Repose, static air support system versus alternating air pressure support surfaces, in a nursing home population at high risk of pressure ulcers. Also, in January 2019, Bruin Biometrics, LLC ("BBI") has been granted US FDA marketing authorization for the SEM Scanner, becoming the world's first FDA-authorised device to objectively alert the clinicians to specific anatomical areas of a patient's body at increased risk for developing a pressure ulcer. Thus, the increasing prevalence of pressure ulcers and the presence of FDA approvals are driving the market.

By end-user, the global wound debridement market is segmented into hospitals, home care, specialty clinics, and others.

The specialty clinics segment is expected to boost the market over the forecast period. For instance, according to a study published in PLOS ONE by academics in Australia and the UK on March 8, 2019, showed that the specialist clinics are the most cost-effective route for the chronic wounds with better results for the patients. Chronic wounds like diabetic foot ulcers and venous leg ulcers are often associated with long-term health conditions. They found the services to be fragmented, with care delivered by a range of healthcare professionals across the primary and secondary settings with poor coordination and communication between health care providers. They have stated that such a disconnected system leads to high costs due to increased healing times, high recurrence rates, complications requiring hospitalization and reduced quality of life for the thousands of patients affected by chronic wounds in Australia.

Global Wound Debridement Market Geographical Analysis

North America is dominating the global wound debridement market in 2018 and estimated to hold significant market size over the forecast period (2019-2026) owing to the product innovations, rise in the incidence of diabetes cases, increasing healthcare spending and the growing aging population in this region.

The increasing number of wound cases in the region are expected to boost the market. For instance, the National Institute of Health has estimated that 3% of the population of 65 years and above would have a wound at some time. An even higher rate of incidence is expected, owing to the traumatic injuries and ulcers endemic in resource-poor countries to other regions. Thus, the rising number of wounds is driving the market.

The ongoing research activities for wound management by the key players in the region is expected to boost the market. According to a study published on August 14, 2019, in the open-access journal PLOS ONE by Brennan Spiegel of Cedars-Sinai Health System and colleagues found that therapeutic virtual reality (VR) is emerging as an active, non-pharmacological treatment modality for pain, anxiety disorders, and distract patients during wound care. Thus, the presence of ongoing research activities are driving the market.

The presence of key players developing wound debridement products in the region are expected to boost the market. For instance, on March 04, 2019 Organogenesis Holdings Inc. announced that PuraPly® Antimicrobial (PuraPly AM) product has positively affected the course of healing in a variety of complex, chronic wounds that were previously unresponsive to treatment. Thus, the presence of key players launching different debridement products are driving the market.

Europe is expected to grow at a high rate in 2018 and is estimated to hold significant market size over the forecast period (2019-2026). This is owing to the rising prevalence of pressure ulcers, and the government initiatives for wound management.

The rising prevalence of pressure ulcers in the region is expected to boost the market. In the UK, recent research from the NHS Improvement showed that treating pressure ulcer costs the NHS more than £3.8m per day and around 1700- 2000 patients per month develop pressure ulcers.

In June 2018, Smith & Nephew announced that the UK's National Institute for Health and Care Excellence (NICE) has issued a Medtech innovation briefing (MIB) on the use of PICO single use Negative Pressure Wound Therapy (sNPWT). The MIB reported the prophylactic use of the PICO as a more effective alternative to the standard surgical dressings in the prevention of surgical site complications (SSCs). According to them, this is the first and the only MIB published by the NICE on an NPWT device for preventing SSCs.

Global Wound Debridement Market Competitive Landscape

The key players operating in the global wound debridement market are B. Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew, Coloplast A/S, ConvaTec Group, Paul Hartmann, Molnlycke Health Care, Lohmann & Rauscher, Medline Industries, and Integra Lifesciences.

The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the wound debridement market globally. For instance,

In June 2019, The Malaysian Society of Wound Care Professionals (MSWCP) announced their program at the 16th Asia Pacific conference on the Diabetic Limb Problems and the 2nd Global Wound Conference 2019.

In June 2019, Molnlycke has acquired a patent application from Innovation Skane, which helped to detect the infections in the wounds. Once developed, the patent is expected to play a significant role in reducing the unnecessary use of antibiotics in wound care.

On January 25, 2019, Radiometer had a partnership with Perimed, which gave Radiometer the ability to sell Perimed's unique wound care system and give Perimed the ability to expand the reach of their product through Radiometer's strong distribution network.

On 9 July 2018, Inotec AMD Limited's NATROX® Oxygen Wound Therapy has earned the prestigious 2018 product leadership award in chronic wound care management from Frost & Sullivan.

On November 27, 2018 Researchers from MedStar Washington Hospital Center and the MedStar Health Research Institute started an Investigational Device Exemption (IDE) trial on full-thickness burn wounds using Kerecis Omega3 Burn.

Why Purchase the Report?

  • Visualize the composition of the global wound debridement market in terms of various products, wound type, method, and end-user highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the global wound debridement market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the global wound debridement market-level 4/5 segmentation.
  • A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players.

The Global Wound Debridement Market report would provide access to an approx, 73 market data tables, 75 figures, and 220 pages

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Wound Debridement Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Wound Debridement Market - Market Definition and Overview

3. Global Wound Debridement Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Wound type
  • 3.3. Market Snippet by Method
  • 3.4. Market Snippet by End-user

4. Global Wound Debridement Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rising incidence of diabetes and obesity
      • 4.1.1.2. The presence of technological advancements in products
    • 4.1.2. Restraints
      • 4.1.2.1. The possible complications after wound debridement
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Wound Debridement Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. Global Wound Debridement Market - By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Market Attractiveness Index, By Product type Segment
  • 6.2. Gels*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    • 6.2.3. Ultrasonic Devices
    • 6.2.4. Surgical devices
    • 6.2.5. Ointments and Creams
    • 6.2.6. Medical Gauze
    • 6.2.7. Mechanical Debridement Pads
    • 6.2.8. Others

7. Global Wound Debridement Market - By Wound type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 7.1.2. Market Attractiveness Index, By Wound type Segment
  • 7.2. Burns*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 7.3. Diabetic Foot Ulcers
  • 7.4. Pressure Ulcers
  • 7.5. Venous Leg Ulcers
  • 7.6. Surgical & Traumatic Wounds
  • 7.7. Others

8. Global Wound Debridement Market - By Method

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 8.1.2. Market Attractiveness Index, By Method Segment
  • 8.2. Surgical Method*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 8.3. Enzymatic Method
  • 8.4. Autolytic Method
  • 8.5. Mechanical Method
  • 8.6. Others

9. Global Wound Debridement Market - By End-user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
    • 9.1.2. Market Attractiveness Index, By End-user Segment
  • 9.2. Specialty Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 9.3. Hospitals
  • 9.4. Home care
  • 9.5. Others

10. Global Wound Debridement Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. The U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

11. Global Wound Debridement Market Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Global Wound Debridement Market Company Profiles

  • 12.1. B. Braun Melsungen AG.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Acelity L.P., Inc.
  • 12.3. Smith & Nephew
  • 12.4. Coloplast A/S
  • 12.5. ConvaTec Group
  • 12.6. Paul Hartmann
  • 12.7. Molnlycke Health Care
  • 12.8. Lohmann & Rauscher
  • 12.9. Medline Industries
  • 12.10. Integra Lifesciences.

LIST NOT EXHAUSTIVE

13. Global Wound Debridement Market - Premium Insights

14. Global Wound Debridement Market - Data M

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us
Back to Top